Mutch DG - Search Results

1

Hereditary Ovarian Cancer and Risk Reduction.

Andrews L, Mutch DG. Andrews L, et al. Among authors: mutch dg. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48. doi: 10.1016/j.bpobgyn.2016.10.017. Epub 2017 Jan 17. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 28254144 Review.

2

Biology of epithelial ovarian cancer.

Mutch DG, Williams S. Mutch DG, et al. Clin Obstet Gynecol. 1994 Jun;37(2):406-22. doi: 10.1097/00003081-199406000-00017. Clin Obstet Gynecol. 1994. PMID: 8033452 Review. No abstract available.

3

Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.

Swisher EM, Babb S, Whelan A, Mutch DG, Rader JS. Swisher EM, et al. Among authors: mutch dg. J Reprod Med. 2001 Feb;46(2):87-94. J Reprod Med. 2001. PMID: 11255821

4

Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.

Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK, Huettner P, Edmonston TB, Goodfellow PJ. Buttin BM, et al. Among authors: mutch dg. Clin Cancer Res. 2004 Jan 15;10(2):481-90. doi: 10.1158/1078-0432.ccr-1110-03. Clin Cancer Res. 2004. PMID: 14760069

5

Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.

Taylor N, Mutch DG. Taylor N, et al. Among authors: mutch dg. Oncology (Williston Park). 2006 Jan;20(1):85-94; discussion 94-6, 100. Oncology (Williston Park). 2006. PMID: 16572595 Review.

6

Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.

Novetsky AP, Smith K, Babb SA, Jeffe DB, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I. Novetsky AP, et al. Among authors: mutch dg. Int J Gynecol Cancer. 2013 Jul;23(6):1016-21. doi: 10.1097/IGC.0b013e3182994365. Int J Gynecol Cancer. 2013. PMID: 23748176 Free PMC article.

7

Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.

Daniels MS, Babb SA, King RH, Urbauer DL, Batte BA, Brandt AC, Amos CI, Buchanan AH, Mutch DG, Lu KH. Daniels MS, et al. Among authors: mutch dg. J Clin Oncol. 2014 Apr 20;32(12):1249-55. doi: 10.1200/JCO.2013.50.6055. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24638001 Free PMC article.

8

Molecular staging of gynecological cancer: What is the future?

Binder PS, Prat J, Mutch DG. Binder PS, et al. Among authors: mutch dg. Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):776-89. doi: 10.1016/j.bpobgyn.2015.01.008. Epub 2015 Mar 4. Best Pract Res Clin Obstet Gynaecol. 2015. PMID: 25934522 Free PMC article. Review.

9

Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.

Griffin NE, Buchanan TR, Smith SH, Leon AA, Meyer MF, Liu J, Tabak RG, Fuh KC, Thaker PH, Powell MA, Mutch DG, Massad LS, Colditz GA, Hagemann AR. Griffin NE, et al. Among authors: mutch dg. Gynecol Oncol. 2020 Jan;156(1):140-146. doi: 10.1016/j.ygyno.2019.11.005. Epub 2019 Nov 25. Gynecol Oncol. 2020. PMID: 31780235

10

Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.

Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, Mutch DG, Herzog TJ. Rader JS, et al. Among authors: mutch dg. Obstet Gynecol. 1998 Oct;92(4 Pt 1):589-95. doi: 10.1016/s0029-7844(98)00275-0. Obstet Gynecol. 1998. PMID: 9764634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page